Veracyte (NASDAQ:VCYT) Now Covered by Craig Hallum
Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors on Thursday, MarketBeat.com reports. The brokerage set a “buy” rating and a $45.00 price target on the biotechnology company’s stock. Craig Hallum’s price target suggests a potential upside of 41.42% from the company’s current […]
Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors on Thursday, MarketBeat.com reports. The brokerage set a “buy” rating and a $45.00 price target on the biotechnology company’s stock. Craig Hallum’s price target suggests a potential upside of 41.42% from the company’s current […]
